Immunity Pharma Ltd.
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Follow up Study to Protocol 101/2 - Continued Treatment by IPL344 IV (NCT03755167) | Immunity Pharma Ltd. | 2018-12-09 |
| A Study of IPL344 in the Treatment of ALS Patients (NCT03652805) | Immunity Pharma Ltd. | 2018-08-01 |
Track Immunity Pharma Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.